Iris Grossman

Company: Eleven Therapeutics

Job title: Chief Therapeutics Officer

Seminars:

Mastermind Discussion: Controlling the System: Leveraging Computational Tools to Control the Level of Expression for mRNA and RNAi Programmable Therapeutics to Develop ‘Smart RNA’ 1:45 pm

How can computational tools be utilized in the development of mRNA & RNAi programmable therapeutics? What is the potential for leveraging ‘smart RNA’ to optimize dosage, timing and minimizing off-target effects?Read more

day: Conference Day Two